These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12070020)

  • 1. Thrombin functions during tissue factor-induced blood coagulation.
    Brummel KE; Paradis SG; Butenas S; Mann KG
    Blood; 2002 Jul; 100(1):148-52. PubMed ID: 12070020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood clotting in minimally altered whole blood.
    Rand MD; Lock JB; van't Veer C; Gaffney DP; Mann KG
    Blood; 1996 Nov; 88(9):3432-45. PubMed ID: 8896408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation in hemophilia A and hemophilia C.
    Cawthern KM; van 't Veer C; Lock JB; DiLorenzo ME; Branda RF; Mann KG
    Blood; 1998 Jun; 91(12):4581-92. PubMed ID: 9616154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet agents in tissue factor-induced blood coagulation.
    Butenas S; Cawthern KM; van't Veer C; DiLorenzo ME; Lock JB; Mann KG
    Blood; 2001 Apr; 97(8):2314-22. PubMed ID: 11290593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation at the site of microvascular injury: effects of low-dose aspirin.
    Undas A; Brummel K; Musial J; Mann KG; Szczeklik A
    Blood; 2001 Oct; 98(8):2423-31. PubMed ID: 11588039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
    van 't Veer C; Golden NJ; Kalafatis M; Mann KG
    J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
    van 't Veer C; Mann KG
    J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma.
    Gerotziafas GT; Depasse F; Chakroun T; Van Dreden P; Samama MM; Elalamy I
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):149-56. PubMed ID: 15091002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.
    Chatterjee MS; Denney WS; Jing H; Diamond SL
    PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20941387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.
    Butenas S; van 't Veer C; Mann KG
    J Biol Chem; 1997 Aug; 272(34):21527-33. PubMed ID: 9261172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
    Hoffman M; Monroe DM; Oliver JA; Roberts HR
    Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
    Butenas S; Brummel KE; Branda RF; Paradis SG; Mann KG
    Blood; 2002 Feb; 99(3):923-30. PubMed ID: 11806995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and phospholipids in tissue factor-initiated thrombin generation.
    Butenas S; Branda RF; van't Veer C; Cawthern KM; Mann KG
    Thromb Haemost; 2001 Aug; 86(2):660-7. PubMed ID: 11522019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The resuscitative fluid you choose may potentiate bleeding.
    Brummel-Ziedins K; Whelihan MF; Ziedins EG; Mann KG
    J Trauma; 2006 Dec; 61(6):1350-8. PubMed ID: 17159676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation: phenotypic quantitation.
    Brummel-Ziedins KE; Pouliot RL; Mann KG
    J Thromb Haemost; 2004 Feb; 2(2):281-8. PubMed ID: 14995991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637.
    Deinum J; Mattsson C; Inghardt T; Elg M
    Thromb Haemost; 2009 Jun; 101(6):1051-9. PubMed ID: 19492147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDEN.
    van 't Veer C; Kalafatis M; Bertina RM; Simioni P; Mann KG
    J Biol Chem; 1997 Aug; 272(33):20721-9. PubMed ID: 9252393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation and secretion of platelet Factor 4 during blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1978 Apr; 61(4):1102-6. PubMed ID: 207723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.